[Federal Register Volume 89, Number 137 (Wednesday, July 17, 2024)]
[Notices]
[Pages 58168-58169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15711]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Advisory
Allergy and Infectious Diseases Council. The meetings will be open to
the public as indicated below, with attendance limited to space
available. Individuals who plan to attend and need special assistance,
such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: September 9, 2024.
Open: 10:30 a.m. to 11:30 a.m.
Agenda: Report of Institute Director.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Closed: 11:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892-9834, (240) 669-5036, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Microbiology and Infectious Diseases Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 2,
Rockville, MD 20892 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 2,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892-9834, (240) 669-5036, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Immunology and Transplantation Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 1,
Rockville, MD 20892 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Garden Room 1,
Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institutes of Health, NIAID, National
Institutes of Health, 5601 Fishers Lane, Room 3F40B, Bethesda, MD
20892-9834, (240) 669-5036, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council Acquired Immunodeficiency Syndrome Subcommittee.
Date: September 9, 2024.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Grand Hall,
Rockville, MD 20892 (Hybrid Meeting).
Open: 1:00 p.m. to 4:00 p.m.
Agenda: Report of the Division Director and Division Staff.
[[Page 58169]]
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Conference Room: Grand Hall, 5601
Fishers Lane, Rockville, MD 20892 (Hybrid Meeting).
Contact Person: Kelly Y. Poe, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F40B,
Bethesda, MD 20892-9834, (240) 669-5036, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a meeting
on campus or at an off-campus federal facility will be asked to show
one form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://www.niaid.nih.gov/about/advisory-council, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-15711 Filed 7-16-24; 8:45 am]
BILLING CODE 4140-01-P